View in EDS

Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.

Saved in:
Bibliographic Details
Title: Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.
Authors: Choueiri TK; Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, USA. Electronic address: toni_choueiri@dfci.harvard.edu., Larkin J; Renal and Skin Units, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK., Pal S; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, USA., Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Rini BI; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, USA., Venugopal B; Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK., Alekseev B; P. Hertsen Moscow Oncology Research Institute, Moscow, Russia., Miyake H; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan., Gravis G; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Inserm, CNRS, CRCM, Marseille, France., Bilen MA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA., Hariharan S; Oncology, Pfizer, New York, USA., Chudnovsky A; Oncology, Pfizer, Cambridge, USA., Ching KA; Computational Biology, Pfizer, San Diego, USA., Mu XJ; Computational Biology, Pfizer, San Diego, USA., Mariani M; Immuno-Oncology, Pfizer, Milan, Lombardia, Italy., Robbins PB; Translational Oncology, Pfizer, San Diego, USA., Huang B; Biostatistics, Pfizer, Groton, USA., di Pietro A; Immuno-Oncology, Pfizer, Milan, Lombardia, Italy., Albiges L; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
Source: ESMO open [ESMO Open] 2021 Jun; Vol. 6 (3), pp. 100101. Date of Electronic Publication: 2021 Apr 23.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33901870
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Choueiri+TK%22">Choueiri TK</searchLink>; Department of Medical Oncology, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, USA. Electronic address: toni_choueiri@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Larkin+J%22">Larkin J</searchLink>; Renal and Skin Units, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.<br /><searchLink fieldCode="AU" term="%22Pal+S%22">Pal S</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, USA.<br /><searchLink fieldCode="AU" term="%22Motzer+RJ%22">Motzer RJ</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Rini+BI%22">Rini BI</searchLink>; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, USA.<br /><searchLink fieldCode="AU" term="%22Venugopal+B%22">Venugopal B</searchLink>; Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK.<br /><searchLink fieldCode="AU" term="%22Alekseev+B%22">Alekseev B</searchLink>; P. Hertsen Moscow Oncology Research Institute, Moscow, Russia.<br /><searchLink fieldCode="AU" term="%22Miyake+H%22">Miyake H</searchLink>; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Gravis+G%22">Gravis G</searchLink>; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, Inserm, CNRS, CRCM, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Bilen+MA%22">Bilen MA</searchLink>; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA.<br /><searchLink fieldCode="AU" term="%22Hariharan+S%22">Hariharan S</searchLink>; Oncology, Pfizer, New York, USA.<br /><searchLink fieldCode="AU" term="%22Chudnovsky+A%22">Chudnovsky A</searchLink>; Oncology, Pfizer, Cambridge, USA.<br /><searchLink fieldCode="AU" term="%22Ching+KA%22">Ching KA</searchLink>; Computational Biology, Pfizer, San Diego, USA.<br /><searchLink fieldCode="AU" term="%22Mu+XJ%22">Mu XJ</searchLink>; Computational Biology, Pfizer, San Diego, USA.<br /><searchLink fieldCode="AU" term="%22Mariani+M%22">Mariani M</searchLink>; Immuno-Oncology, Pfizer, Milan, Lombardia, Italy.<br /><searchLink fieldCode="AU" term="%22Robbins+PB%22">Robbins PB</searchLink>; Translational Oncology, Pfizer, San Diego, USA.<br /><searchLink fieldCode="AU" term="%22Huang+B%22">Huang B</searchLink>; Biostatistics, Pfizer, Groton, USA.<br /><searchLink fieldCode="AU" term="%22di+Pietro+A%22">di Pietro A</searchLink>; Immuno-Oncology, Pfizer, Milan, Lombardia, Italy.<br /><searchLink fieldCode="AU" term="%22Albiges+L%22">Albiges L</searchLink>; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2021 Jun; Vol. 6 (3), pp. 100101. <i>Date of Electronic Publication: </i>2021 Apr 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33901870
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.esmoop.2021.100101
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100101
    Titles:
      – TitleFull: Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Choueiri TK
      – PersonEntity:
          Name:
            NameFull: Larkin J
      – PersonEntity:
          Name:
            NameFull: Pal S
      – PersonEntity:
          Name:
            NameFull: Motzer RJ
      – PersonEntity:
          Name:
            NameFull: Rini BI
      – PersonEntity:
          Name:
            NameFull: Venugopal B
      – PersonEntity:
          Name:
            NameFull: Alekseev B
      – PersonEntity:
          Name:
            NameFull: Miyake H
      – PersonEntity:
          Name:
            NameFull: Gravis G
      – PersonEntity:
          Name:
            NameFull: Bilen MA
      – PersonEntity:
          Name:
            NameFull: Hariharan S
      – PersonEntity:
          Name:
            NameFull: Chudnovsky A
      – PersonEntity:
          Name:
            NameFull: Ching KA
      – PersonEntity:
          Name:
            NameFull: Mu XJ
      – PersonEntity:
          Name:
            NameFull: Mariani M
      – PersonEntity:
          Name:
            NameFull: Robbins PB
      – PersonEntity:
          Name:
            NameFull: Huang B
      – PersonEntity:
          Name:
            NameFull: di Pietro A
      – PersonEntity:
          Name:
            NameFull: Albiges L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2021 Jun
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2059-7029
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: ESMO open
              Type: main
ResultId 1